Top
Events

Théa news

Find out all the latest news on Théa

 To consolidate its presence on the front of research and innovation, Théa participates in all national and international congresses and meetings dedicated to ophthalmology and opted to partner many subspecialty meetings.

Congresses, conferences, product launches, scientific innovation, innovation, new offices, Théa is always on the move.

 

 

Press
New partnership between Théa Open Innovation and Kiora Pharmaceuticals

Théa signs licensing agreement with Kiora Pharmaceuticals.

more

Corporate
Théa celebrates its 30th anniversary

30 years of innovation, education, commitment and proximity.

more

HR
Théa awarded the Happy Trainees® label

Théa awarded the Happy Trainees® label

more

Press
Partnership signed with Link Biologics

Théa and Link Biologics sign licensing agreement

more

Press
Partnership signed with ProQR Therapeutics

Théa and ProQR Therapeutics sign licensing agreement

more

Press
New production site in La Rochelle

Théa has annouced plans to invest €10 million for a new flagship production facility in La Rochelle, and further on-site expansion is projected. 

more

Corporate
Opening of the 11th Trophy

The 11th edition of Trophy is now open and will focus on "The Secret To Ocular Surface Success: Don't Forget Eyelids!". 

 

 

more

Corporate
Inauguration of Théa Czech Republic and Slovakia

Théa Czech Republic and Slovakia affiliate official opening ceremony was held on Friday June 16 at French embassy in Prague.

Welcome to the Théa family!

 

 

more

Corporate
EY Awards: Jean-Fréderic Chibret's career

On Friday 9 June, in Monaco, the award ceremony for the EY World Entrepreneur of the Year was held. 

 

more

Corporate
Official launch of our new subsidiary in Peru!

Théa Péru was offially launched on Thurday 18 May in Lima! 

Théa Peru is the second Théa subsidiary in South America after Théa Chile, which started last year.

 

more

Corporate
Théa and Galimedix

Théa and Galimedix enter into Licensing Agreement  for the development and commercialization of GAL-101.

 
 

 

more

Corporate
Théa and Tsubota

Théa and Tsubota enter into Licensing Agreement or the development, manufacture and commercialization of TLM-003.

 
 

 

more

Corporate
Climate Fresk

Introduction to a series of "Climate Fresk" workshops at Théa.

 
 

 

more

Corporate
Press Release: IYUZEH™

Théa Announces FDA Approval of IYUZEH™

 

 

more

Corporate
National EY Entrepreneur of the Year Award 2022

Jean-Frédéric Chibret, president of Laboratoires Théa, won last night in Paris the National EY Entrepreneur of the Year 2022 award.

 
 

 

more

Corporate
World Sight Day 2022

October 13th is World Sight Day
 
 

 

more

Corporate
EY Entrepreneur of the Year Award 2022

Jean-Frédéric Chibret, president of Laboratoires Théa, won last night at the hotel de Ville de Lyon the EY Entrepreneur of the Year 2022 award for the Auvergne Rhône Alpes region.

 
 

 

more

Education
Théa Innovation

The leading European ophthalmology pharmaceutical company is the first to offer an innovative hyaluronic acid treatment for the management of dry eye. 

 

more

Education
Théa and its partnerships

Education and knowledge sharing have always been a tradition for the Chibret family. That's why Théa supports many educational projects and activities.

 

more

Education
Dry eye and symptoms

Dry eye, also known as dry eye disease, dry eye syndrome or keratoconjunctivitis sicca (KCS), is one of the most frequent reasons people see an ophthalmologist. 

 

more

A look back at the Helen Keller Europe evening
Helen Keller Award

Henri Chibret received the "Spirit of Helen Keller Award", honouring his major contribution to ophthalmology research and prevention of blindness worldwide.

 

more

Back to Ocular Surface Masterclass
Knowledge Sharing

Over 100 international dry eye experts were meeting on May 13th at the Institute of Ocular Microsurgery (IMO) to take part in an “Ocular Surface Masterclass”
more

Ocular Surface Masterclass
Knowledge Sharing

Jean-Fréderic Chibret opened the 3rd Edition of Ocular Surface Master Class event. 
more

Corporate
April is Women's Eye Health and Safety Month!

Did you know that women are more likely to suffer from vision problems?
more

Innovation
3 questions for .... Colin Francou

Colin Francou, Théa Open Innovation Managing Director, speaks about Théa Open Innovation. 
more

Corporate
"At the heart of the G5 Health sites”

Théa participates in the first edition of the operation led by the G5
more

Education
Launch of the Théacademy website

Discover the new platform dedicated to ophthalmologists : www.thea-academy.com

more

Event
World Glaucoma Week

The "World Glaucoma Week", from 6th to 12th March is an initiative that wants to raise awareness of the world population on this disease.

more

Opening of Théa Czech Republic subsidiary
International

Théa is welcoming a new subsidiary : Théa Czech Republic

more

Education
Trophy Winners

Discover the 3 winners of the Trophy Contest 2020-2022 edition.
more

Partnership
Signature of a new partnership between Théa and Akorn

Théa announces the acquisition of 7 Akorn-branded ophthalmic products
more

Event
Discover the podcast of Jean-Frédéric Chibret

Listen to Jean-Frédéric’s “fireside chat” recorded during the last OIS meeting.
more

Event
World Sight Day 2021

Today is World Sight Day, a day created by the IAPB (International Agency for the Prevention of Blindness), in collaboration with the WHO.
more

Education
Trophy Contest

More days to submit! We’ve extended the entry deadline for the Trophy contest, which means you’ve still got time to submit your clinical case on “When glaucoma and ocular surface disease collide”. 
more

Innovation
Théa and Coave Therapeutics sign an exclusive agreement

Théa and Coave Therapeutics sign an exclusive licensing, co development and commercialization agreement
more

Interview
Attractiveness in Auvergne: a major asset of Europe’s health independence

Watch the full interview of Jean-Frédéric Chibret
more

Partnership
Partnership between the European Investment Bank (EIB) and Théa

The EIB will support the Research and Development of Théa by according 50 million euros to the company.
 
more

Partnership
Théa invests in the United States

Théa continues its international expansion in the American continent and opens a new subsidiary in the United States.

more

Théa and Europe
Our European roots

Théa belongs to a select circle of pharmaceutical companies with subsidiaries at the continent’s four cardinal points. Throwback to Théa's European construction.

 

 

more

Event
World Glaucoma Week 2021

World Glaucoma Week (March 7-13) is a global initiative of the World Glaucoma Association (WGA) to raise awareness on glaucoma.

 

more

Fondation
Fondation Théa Movie

The Fondation Théa aims to promote or assist, in France and abroad, humanitarian or general interest initiatives to aid the fight against blindness and improve eye health. Discover the movie.
more

Education
Education Movie

Innovation is not Théa’s only priority. Education and the sharing of knowledge have always been an important tradition for the Chibret family. Théa supports many projects and pedagogical activities. Discover the movie.
more

Press
Théa and Innovation

Théa, the leading European pharmaceutical group in ophthalmology (excluding the retina market), increases its research and clinical trials capacity by doubling its innovation space footprint at the headquarters in Clermont-Ferrand.

more

EGS x DryLab sessions
Education

The 14th EGS Resident Course held 18–19th September in Lisbon featured a series of DryLab sessions where internationally-acclaimed faculty supervised hands-on glaucoma surgery training for young ophthalmologists from across Europe.

more

Biocorp and Laboratoires Théa
Partnership

BIOCORP and Laboratoires Théa sign a partnership for the development of innovative digital solutions.

more

World Sight Day
Let's Open Our Eyes

We live in a beautiful world, but not everyone can see it. 253 million people suffer from vision impairment and 36 million are blind or going blind. Yet, 80% of all vision impairment can now be prevented, treated or cured.

more

DryLab sessions for young ophthalmologists
Never Stop Learning

Théa organized DryLab session workshops dedicated specifically for young ophthalmologists from 23 different countries, at this year’s big SOE conference.

more

8th TROPHY contest
Never Stop Learning

The 2019-2020 TROPHY contest is declared open.

more

Théa at the SOE 2019
Never Stop Learning

Among the 2,500 participants, more than 400 young ophthalmologists from 24 countries attended the SOE 2019 in Nice.

more

5th Eye Nutrition Meeting
Never Stop Learning

More than 100 ophthalmologists from 18 countries attended the 5th ENM forum on the latest news and developments in ocular health.

more

let’s open our eyes: Théa’s new signature around the world
Théa

This year marks Théa’s 25th anniversary and we are taking this opportunity to update our identity. “let’s open our eyes” becomes Théa’s new signature around the world.

more

Focus on the 7th Théa TROPHY contest award ceremony
Théa event

The 7th Théa TROPHY contest award ceremony took place in Vancouver at ARVO 2019.

 

 

more

Pathology
World Glaucoma Week

World Glaucoma Week is now right around the corner (from March 10 to 16) and we need to get people to talk about it!

 

 

 

more

Knowledge sharing
Ocular Surface Masterclass

Over one hundred international dry eye experts will be meeting this Friday at the Institute of Ocular Microsurgery (IMO) to take part in an “Ocular Surface Masterclass,” to present and put into practice the latest advancements in dealing with dry eye disease.

more

Knowledge sharing
TROPHY community gathered at EVER 2018

Théa brought together the thirteen national winners of the 6th clinical case contest, TROPHY, in Nice from October 3 to 6, 2018. 

more

“The eye in history”
A new volume in the Théa Medical Library

STARS : identifier la DMLA chez les patients à risque

Most of the things we take for granted today did not just happen. In this new book of the Théa Medical Library collection, Professor Harminder S. DUA and Mr. Richard KEELER take us on a journey through the history of ophthalmic instruments and treatments.

more

Théa opens its 27th subsidiary, Théa Chile
International development

STARS : identifier la DMLA chez les patients à risque

After Central America (Mexico), the Group is expanding into South America. On April 19, 2018, Mr. Roland DUBERTRAND, ambassador of France to Chile, celebrated the creation of Théa's new Chilean subsidiary.

more

Record participation for 6th TROPHY
Event

STARS : identifier la DMLA chez les patients à risque

220 young ophthalmologists from more than 21 countries submitted clinical cases in answer to the topic of the sixth edition of the TROPHY contest – ‘novel management of  ocular surface diseases’.

more

Laboratoires THEA attended the 13th European Glaucoma Society (EGS) Congress, in Florence, Italy.
Education

STARS : identifier la DMLA chez les patients à risque

Laboratoires THEA attended the 13th European Glaucoma Society (EGS) Congress which took place in Florence, Italy from 19 to 22 May 2018.

more

Thea supports Ophthalmologists at recent Birmingham meeting
Education

STARS : identifier la DMLA chez les patients à risque

Thea UK were delighted to support the Thea Birmingham Corneal Meeting recently.

more

DRY LAB workshops for young ophthalmologists
Education

STARS : identifier la DMLA chez les patients à risque

During 2 vital national conferences; Théa France organised its first DRY LAB workshops dedicated to young ophthalmologists.

more

Laboratoires Théa partner of ESCRS Winter 2018
Education

STARS : identifier la DMLA chez les patients à risque

Laboratoires THEA participated in the 22nd European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting, which took place in Belgrade, Serbia, from 9 to 11 February 2018, a great opportunity to meet Eastern Europe's ophthalmologists.

more

Théa welcomes 400 ophthalmologists at JRO
Education

STARS : identifier la DMLA chez les patients à risque

For the seventh consecutive year, Théa organised a France/Maghreb meeting with Dr Lazreg & Dr Santiago on the theme of surgical retina. 400 ophthalmologists participated in this event at the 18th Ophthalmological Reflections Days in Paris.

more

Partnership
Théa is entering the retina field by virtue of an agreement concluded with ELSALYS BIOTECH

STARS : identifier la DMLA chez les patients à risque

The THEA laboratories are expanding their portfolio to include the retina owing to a licence option on an antibody in the treatment of humid AMD, and other retina vascular pathologies: ELB011.
more

Event
An unprecedented meeting!

STARS : identifier la DMLA chez les patients à risque

On Thursday, 25 January 2018, Jean-Frédéric CHIBRET met with Mr Emmanuel MACRON, President of the French Republic.
more

Education
THEA at the ESCRS 2017partner through activities during ESCRS

STARS : identifier la DMLA chez les patients à risque

THEA provides surgeons with innovative products as well as YOs with DRY LAB sessions to develop surgical skills.
New ways to prevent ocular dryness and simplified management of cataract patient thanks to intracameral injection
have been raised during educational symposia.
more

Event
Frank G. Holz receives the Paul Chibret medal

STARS : identifier la DMLA chez les patients à risque

Prof. Dr. Med. Frank G. Holz was awarded the Paul Chibret medal at the DOG 2017 Congress in Berlin.
more

Innovation by Théa
Trehalose in the spotlight of the TFOS DEWS II

STARS : identifier la DMLA chez les patients à risque

For the first time, the TFOS has officially acknowledged trehalose as an effective ingredient in association with hyaluronic acid for the treatment of dry eye syndrome.
more

Event
TROPHY competition 5th edition

STARS : identifier la DMLA chez les patients à risque

116 young ophthalmologists from over 21 countries submitted a clinical case in response to the subject chosen for the TROPHY 5th edition: “The non-surgical treatment of corneal diseases”.

more

Industry
Production practically doubled!

STARS : identifier la DMLA chez les patients à risque

The Fareva group, and more specifically its subsidiary Excelvision, has opened a new single-dose sterile production unit with Théa Laboratories. This new building will be capable of manufaturing 800 million preservative-free single doses per year, as opposed to the 500 million produced today.

more

Théa Worldwide
Launching Théa Pharmaceuticals in the Middle East

STARS : identifier la DMLA chez les patients à risque

Following Mexico in 2014, Morocco and Russia in 2015 and Ukraine in 2016, it is now Dubai’s turn to witness the opening of a new subsidiary of Théa Laboratories.

more

Event
3rd Eye Nutrition Meeting

STARS : identifier la DMLA chez les patients à risque

90 ophthalmologists from 14 different countries attended a Théa event on the latest developments in eye health, including the benefits of nutrition, predominantly vitamin D.

more

Education to surgery by Théa
THEA supports YOs to develop surgical skills

STARS : identifier la DMLA chez les patients à risque

THEA organised and sponsored the 1st international dry lab session during the SOE Congress in Barcelona (June 2017) in partnership with the YO-SOE Board. As education is part of Thea’s ethos we are advancing into providing Surgical Skills Training for Young Ophthalmic surgeons using the latest innovative apparatus and simulation eyes.
more

AMD
STARS: 13 risks factors to identify patients at risk of AMD

STARS: 13 risks factors to identify patients at risk of AMDA new simple and fast questionnaire has been developed by Laboratoires Théa in order to assess early AMD risk.

more

Ophthalmic surgical world
How to generate fast dilation?

Thanks to many years of experience and intense research, Théa has found a new way to generate faster and stable dilation. Taking the opportunity of the ESCRS international congress, Théa shared this innovation with several thousand ophthalmologists coming from all over Europe.

more

A new book on how to manage chronic corneal ulcers.
« Chronic Corneal Ulcers »

« Chronic Corneal Ulcers » European ophthalmological professors have joined together in order to present an all-encompassing book on the complicated topic of Chronic Corneal Ulcers.

This book is aimed at ophthalmologists in order to improve cornea care.

more

History
« Les Chibret, une saga auvergnate (1875-2015) »

Book "Les Chibret, une saga auvergnate (1875-2015)"Written by Lorraine Kaltenbach under the direction of Henri Chibret, this saga relates the history of the Chibret’s family since the French revolution up until today; but above all the close relationship that family members have always maintained

with ophthalmological workers.

more

Fifteen years of innovation
15th anniversary of Théa PHARMA, Switzerland

 

Team Thea PHARMA SWITZERLANDFounded in 2001, Théa PHARMA Switzerland began their journey with only 2 products.

Today their range of both innovative and well-known products covers almost every ophthalmological therapeutic class.

more

Education
Théa, partner of the Young Ophthalmologists

The second edition of the European Meeting of Young Ophthalmologists took place in June in Oviedo, Spain. Laboratoires Théa, represented by Jean-Frédéric Chibret, the President of the company, was the main partner and sponsor of the event.

more

Innovation by Théa
A new era in mydriasis


Théa is very keen on innovating in all therapeutic areas in ophthalmology, including cataract surgery. 

To develop its new product indicated in the mydriasis (pupil dilation) for patients undergoing cataract surgery, Théa set up clinical studies to demonstrate the efficacy and the safety of the product.

more

Théa worldwide
Official opening of the Théa office in Ukraine

After Mexico in 2014, Morocco and Russie in 2015, it is now in Ukraine that Théa has opened their latest new representative office.The Ambassador of France in Ukraine, Isabelle Dumont, Prof. Vitovska, the Head of Ukrainian ophthalmologists and

Jean-Frédéric Chibret, President of Théa, were present for this event.

more

Théa worldwide
15th anniversary of Théa Pharma Belgium

The Théa story in Belgium started in 2000 when Théa accepted the challenge to break new ground in preservative-free eye care in Benelux.

more

Careers
Developing international mobility

Supporting the integration and mobility of employees across the Group is Théa’s aspiration to ensure the career development of each individual.

more

Preservative free
A new brochure on 25 years of Preservative-free eye drops

Preservative-free is in the DNA of Laboratoires Théa and is part of its history. Increase the awareness of the ophthalmologists to the importance of Preservative-free eye drops remains a priority with one goal: 0% Preservatives.

more

Glaucoma treatment
a new association of anti-glaucoma active ingredients in a preservative-free bottle


Innovation in the area of preservative-free eye drops is one of the most important interests of Théa’s research and development.

Théa Pharma Germany presented the new Théa preservative-free association of two anti-glaucoma active ingredients at the DOG congress in Düsseldorf in March 2016. This product is distributed in a multidose bottle using EasyGrip® technology.

more